A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]
Recruiting · NCT07390383 · Registry updated 2026-05-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04] | Advanced Solid Tumour | Recruiting | Phase 2 | 2026-05-13 | NCT07390383 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanjing Leads Biolabs Co.,Ltd | 13 |
| Peking University Cancer Hospital & Institute | 189 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Beijing GoBroad Hospital | Beijing | China | 3 |
| Shandong Cancer Hospital | Jinan | China | 86 |
| Shanxi Provincial Cancer Hospital | Taiyuan | China | 20 |
| The Affiliated Hospital of Qingdao University | Qingdao | China | 50 |
| the Fourth Hospital of Hebei Medical University | Shijiazhuang | China | 19 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 6 |